Strategic Marketing & Global Partnerships
At Alverstone, we are committed to building strong, value-driven partnerships that align with our mission of delivering high-quality pharmaceutical products. Our global business development team actively collaborates with companies that share our work ethics, commitment to patients, and innovation-driven approach.
KEY FEATURES
Diverse Pharmaceutical Product Portfolio
Our manufacturing operations focus on producing a wide range of pharmaceutical products, including generics, branded generics, specialty medicines, and over-the-counter (OTC) products. We cater to various therapeutic segments, ensuring that our medicines meet the diverse needs of global healthcare markets.
Expanding Our Reach Through Strategic Alliances
We continuously seek new partnerships to expand our market presence, offering generic and specialty generic (505(b)2) products across international markets. Our history of successful product launches positions us as a trusted partner in the global pharmaceutical landscape.
Innovative Licensing & Technology Integration
To drive continued growth, we actively in-license technology-based specialty generics such as long-acting injectables, liposomes, implants, drug-device combinations, and oral films. These innovations enable us to provide advanced healthcare solutions that improve patient outcomes.
Flexible Business Models for Mutually Beneficial Growth
We believe in fostering long-term, mutually rewarding business relationships through flexible models like co-development, licensing, and fee-for-service arrangements. Our dedicated team provides technical expertise to support our partners in achieving shared success.
